Regulatory pathways for OTC drugs and dietary supplements, including OMUFA and Rx to OTC switch.
2025 · 2nd Quarter (Apr 1 - June 30)
CHATTEM, INC D/B/A OPELLA
Filed by CHATTEM, INC D/B/A OPELLA.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 18, 2025
- Income
- Not reported
- Expenses
- $180,000.00
- Registrant
- CHATTEM, INC D/B/A OPELLA
- Filing UUID
- 3db3a8fc-653d-4171-aeaa-b78826537466
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Retail and cargo theft of medicines, counterfeit and diverted medicines.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.